These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 19520290)
21. Bio-affinity of copper(II) complexes with nitrogen and oxygen donor ligands: Synthesis, structural studies and in vitro DNA and HSA interaction of copper(II) complexes. Jain S; Khan TA; Patil YP; Pagariya D; Kishore N; Tapryal S; Naik AD; Naik SG J Photochem Photobiol B; 2017 Sep; 174():35-43. PubMed ID: 28753522 [TBL] [Abstract][Full Text] [Related]
22. Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia. Vāvere AL; Lewis JS Dalton Trans; 2007 Nov; (43):4893-902. PubMed ID: 17992274 [TBL] [Abstract][Full Text] [Related]
24. Human serum albumin as a copper source for anticancer thiosemicarbazones. Schaier M; Falcone E; Prstek T; Vileno B; Hager S; Keppler BK; Heffeter P; Koellensperger G; Faller P; Kowol CR Metallomics; 2023 Aug; 15(8):. PubMed ID: 37505477 [TBL] [Abstract][Full Text] [Related]
25. Copper(II) bis(thiosemicarbazone) complexes as potential tracers for evaluation of cerebral and myocardial blood flow with PET. Green MA; Klippenstein DL; Tennison JR J Nucl Med; 1988 Sep; 29(9):1549-57. PubMed ID: 3261785 [TBL] [Abstract][Full Text] [Related]
26. Retention of the radiotracers 64Cu-ATSM and 64Cu-PTSM in human and murine tumors is influenced by MDR1 protein expression. Liu J; Hajibeigi A; Ren G; Lin M; Siyambalapitiyage W; Liu Z; Simpson E; Parkey RW; Sun X; Oz OK J Nucl Med; 2009 Aug; 50(8):1332-9. PubMed ID: 19617332 [TBL] [Abstract][Full Text] [Related]
27. Copper(II) complexes with highly water-soluble L- and D-proline-thiosemicarbazone conjugates as potential inhibitors of Topoisomerase IIα. Bacher F; Enyedy É; Nagy NV; Rockenbauer A; Bognár GM; Trondl R; Novak MS; Klapproth E; Kiss T; Arion VB Inorg Chem; 2013 Aug; 52(15):8895-908. PubMed ID: 23829568 [TBL] [Abstract][Full Text] [Related]
28. Superoxide dismutase activity of the naturally occurring human serum albumin-copper complex without hydroxyl radical formation. Kato R; Akiyama M; Kawakami H; Komatsu T Chem Asian J; 2014 Jan; 9(1):83-6. PubMed ID: 24227376 [TBL] [Abstract][Full Text] [Related]
29. Studies of copper(II) binding to glycylglycyl-L-tyrosine-N-methyl amide, a peptide mimicking the NH2-terminal copper(II)-binding site of dog serum albumin by analytical potentiometry, spectrophotometry, CD, and NMR spectroscopy. Muller D; Decock-Le Révérend B; Sarkar B J Inorg Biochem; 1984 Jul; 21(3):215-26. PubMed ID: 6470702 [TBL] [Abstract][Full Text] [Related]
30. Increasing intracellular bioavailable copper selectively targets prostate cancer cells. Cater MA; Pearson HB; Wolyniec K; Klaver P; Bilandzic M; Paterson BM; Bush AI; Humbert PO; La Fontaine S; Donnelly PS; Haupt Y ACS Chem Biol; 2013 Jul; 8(7):1621-31. PubMed ID: 23656859 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of a potential generator-produced PET tracer for cerebral perfusion imaging: single-pass cerebral extraction measurements and imaging with radiolabeled Cu-PTSM. Mathias CJ; Welch MJ; Raichle ME; Mintun MA; Lich LL; McGuire AH; Zinn KR; John EK; Green MA J Nucl Med; 1990 Mar; 31(3):351-9. PubMed ID: 2308007 [TBL] [Abstract][Full Text] [Related]
32. Analysis of the Interaction of Dp44mT with Human Serum Albumin and Calf Thymus DNA Using Molecular Docking and Spectroscopic Techniques. Xu Z; Liu Y; Zhou S; Fu Y; Li C Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27376275 [TBL] [Abstract][Full Text] [Related]
33. Example of two novel thiocyanato bridged copper (II) complexes derived from substituted thiosemicarbazone ligand: structural elucidation, DNA/albumin binding, biological profile analysis, and molecular docking study. Biswas N; Saha S; Khanra S; Sarkar A; Prasad Mandal D; Bhattacharjee S; Chaudhuri A; Chakraborty S; Roy Choudhury C J Biomol Struct Dyn; 2019 Jul; 37(11):2801-2822. PubMed ID: 30101692 [TBL] [Abstract][Full Text] [Related]
34. In vitro kinetic studies on the mechanism of oxygen-dependent cellular uptake of copper radiopharmaceuticals. Holland JP; Giansiracusa JH; Bell SG; Wong LL; Dilworth JR Phys Med Biol; 2009 Apr; 54(7):2103-19. PubMed ID: 19287086 [TBL] [Abstract][Full Text] [Related]
35. Copper bis(thiosemicarbazone) complexes modulate P-glycoprotein expression and function in human brain microvascular endothelial cells. Pyun J; McInnes LE; Donnelly PS; Mawal C; Bush AI; Short JL; Nicolazzo JA J Neurochem; 2022 Aug; 162(3):226-244. PubMed ID: 35304760 [TBL] [Abstract][Full Text] [Related]
36. Validation of 64Cu-ATSM damaging DNA via high-LET Auger electron emission. McMillan DD; Maeda J; Bell JJ; Genet MD; Phoonswadi G; Mann KA; Kraft SL; Kitamura H; Fujimori A; Yoshii Y; Furukawa T; Fujibayashi Y; Kato TA J Radiat Res; 2015 Sep; 56(5):784-91. PubMed ID: 26251463 [TBL] [Abstract][Full Text] [Related]
37. Copper complexes of bis(thiosemicarbazones): from chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals. Paterson BM; Donnelly PS Chem Soc Rev; 2011 May; 40(5):3005-18. PubMed ID: 21409228 [TBL] [Abstract][Full Text] [Related]
38. Interaction studies of copper complex containing food additive carmoisine dye with human serum albumin (HSA): Spectroscopic investigations. Shahabadi N; Akbari A; Jamshidbeigi M; Fili SM Luminescence; 2017 Nov; 32(7):1319-1327. PubMed ID: 28524270 [TBL] [Abstract][Full Text] [Related]
39. Copper complexes of thiosemicarbazone-pyridylhydrazine (THYNIC) hybrid ligands: a new versatile potential bifunctional chelator for copper radiopharmaceuticals. Cowley AR; Dilworth JR; Donnelly PS; White JM Inorg Chem; 2006 Jan; 45(2):496-8. PubMed ID: 16411680 [TBL] [Abstract][Full Text] [Related]
40. Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands. Sun X; Wuest M; Weisman GR; Wong EH; Reed DP; Boswell CA; Motekaitis R; Martell AE; Welch MJ; Anderson CJ J Med Chem; 2002 Jan; 45(2):469-77. PubMed ID: 11784151 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]